Detalhe da pesquisa
1.
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).
Gastric Cancer
; 27(3): 580-589, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243037
2.
Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
Gastric Cancer
; 27(2): 366-374, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180622
3.
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Gastric Cancer
; 27(1): 155-163, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989806
4.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer
; 27(2): 375-386, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281295
5.
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
Jpn J Clin Oncol
; 54(2): 206-211, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952093
6.
Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
World J Surg
; 48(1): 163-174, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686798
7.
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
Int J Clin Oncol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753042
8.
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
Int J Clin Oncol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722486
9.
Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
Dis Esophagus
; 37(5)2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266034
10.
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
BMC Cancer
; 23(1): 726, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543568
11.
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol.
BMC Cancer
; 23(1): 987, 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845660
12.
Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.
Dis Colon Rectum
; 66(3): 401-409, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239524
13.
Evaluation of clinical effects of a multidisciplinary-collaborated cancer support team for gastrointestinal cancer chemotherapy: prospective observational study protocol of M-CAST study.
BMC Gastroenterol
; 23(1): 215, 2023 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337152
14.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer
; 26(1): 132-144, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316527
15.
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
Gastric Cancer
; 26(2): 307-316, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695982
16.
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
Gastric Cancer
; 26(4): 614-625, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029843
17.
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer.
Future Oncol
; 19(32): 2147-2155, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882373
18.
Late complication after gastrectomy for clinical stage I cancer: supplementary analysis of JCOG0912.
Surg Endosc
; 37(4): 2958-2968, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512122
19.
Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer.
Int J Clin Oncol
; 28(8): 1043-1053, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208499
20.
Clinical factors associated with noncurative endoscopic submucosal dissection for the expanded indication of intestinal-type early gastric cancer: Post hoc analysis of a multi-institutional, single-arm, confirmatory trial (JCOG0607).
Dig Endosc
; 35(4): 494-502, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286956